Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy - PubMed (original) (raw)

Review

Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy

F R Derubertis et al. Diabetes. 1994 Jan.

Abstract

Protein kinase C (PKC) is activated in rat renal glomerulus within a week of induction of experimental diabetes. Studies in isolated glomeruli and in cultured endothelial and mesangial cells have demonstrated that high ambient concentrations of glucose activate PKC and thus implicate hyperglycemia per se as a mediator of PKC activation in glomerular cells in diabetes. High glucose concentrations activate PKC by increasing cellular levels of diacylglycerol (DAG), the major endogenous modulator of this signalling system. In contrast to physiological extracellular stimuli of PKC that increase cellular DAG levels by receptor-mediated enhancement of membrane inositol phospholipid hydrolysis, in glomerular cells high concentrations of glucose increase DAG by de novo synthesis from glycolytic intermediates. Activation of PKC by glucose or other agonists increases the permeability of endothelial cells to albumin and stimulates matrix protein synthesis in mesangial cells; it thereby may be involved in the pathogenesis of both the functional and structural alterations of the glomerulus in diabetes. Recent studies in isolated glomeruli from diabetic rats have also implicated activation of PKC in suppression of nitric oxide (NO)-mediated increases in glomerular cGMP generation in response to cholinergic stimuli. In mesangial cells, cGMP suppresses PKC-mediated increases in matrix protein synthesis. Thus, impaired NO-mediated cGMP generation in glomeruli of diabetic individuals may amplify matrix protein synthesis in response to hyperglycemia and other stimuli of PKC. These and other observations suggest that activation of the PKC system by hyperglycemia may represent an important pathway by which glucotoxicity is transduced in susceptible cells in diabetes.

PubMed Disclaimer

Cited by

SIRT6's function in controlling the metabolism of lipids and glucose in diabetic nephropathy.
Wang Y, Liu T, Cai Y, Liu W, Guo J. Wang Y, et al. Front Endocrinol (Lausanne). 2023 Oct 9;14:1244705. doi: 10.3389/fendo.2023.1244705. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37876546 Free PMC article. Review.
Insight into the Molecular Mechanism of Diabetic Kidney Disease and the Role of Metformin in Its Pathogenesis.
Kleibert M, Zygmunciak P, Łakomska K, Mila K, Zgliczyński W, Mrozikiewicz-Rakowska B. Kleibert M, et al. Int J Mol Sci. 2023 Aug 22;24(17):13038. doi: 10.3390/ijms241713038. Int J Mol Sci. 2023. PMID: 37685845 Free PMC article. Review.
Augmentation of Cathepsin Isoforms in Diabetic db/db Mouse Kidneys Is Associated with an Increase in Renal MARCKS Expression and Proteolysis.
Gholam MF, Bala N, Dogan YE, Alli AA. Gholam MF, et al. Int J Mol Sci. 2023 Aug 5;24(15):12484. doi: 10.3390/ijms241512484. Int J Mol Sci. 2023. PMID: 37569859 Free PMC article.
Effects of advanced glycation end products (AGEs) on the differentiation potential of primary stem cells: a systematic review.
Xu K, Zhang L, Yu N, Ren Z, Wang T, Zhang Y, Zhao X, Yu T. Xu K, et al. Stem Cell Res Ther. 2023 Apr 11;14(1):74. doi: 10.1186/s13287-023-03324-5. Stem Cell Res Ther. 2023. PMID: 37038234 Free PMC article. Review.
Immune Modulation by Myeloid-Derived Suppressor Cells in Diabetic Kidney Disease.
Hsieh CC, Chang CC, Hsu YC, Lin CL. Hsieh CC, et al. Int J Mol Sci. 2022 Oct 31;23(21):13263. doi: 10.3390/ijms232113263. Int J Mol Sci. 2022. PMID: 36362050 Free PMC article. Review.

Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy - PubMed (original) (raw)